临床医学论著

腹膜透析对糖尿病尿毒症患者透析效果与生活质量的影响

  • 李华青 ,
  • 丘昭文 ,
  • 林冲云
展开
  • 福建医科大学附属龙岩第一医院肾内科,福建龙岩 364000

收稿日期: 2017-07-15

  网络出版日期: 2017-09-26

Effect of peritoneal dialysis on the dialysis effect and quality of life in diabetic patients with uremia

  • LI Huaqing ,
  • QIU Zhaowen ,
  • LIN Chongyun
Expand
  • Nephrology Department of Longyan the First Hospital Affiliated to Fujian Medical University, Longyan 364000, China

Received date: 2017-07-15

  Online published: 2017-09-26

摘要

目的: 探讨腹膜透析对糖尿病尿毒症患者透析效果与生活质量的影响。方法: 选择2015年8月至2016年8月收治的糖尿病尿毒症患者90例,随机分为观察组和对照组,各45例。对照组采用血液透析治疗,观察组采用腹膜透析治疗。对比两组患者治疗前与治疗12周后血尿素氮(BUN)、血肌酐(SCr)、24 h尿量、24 h尿蛋白水平及生活质量的变化。结果: 观察组治疗后BUN、SCr、24 h尿蛋白水平均低于对照组(P<0.05),24 h尿量高于对照组(P<0.05)。观察组治疗后情感职能、生理功能、躯体疼痛、社会功能与总体健康评分均高于同期对照组(P<0.05)。结论: 腹膜透析在糖尿病尿毒症患者中具有较好的透析效果,且能够改善生活质量,适于临床推广。

本文引用格式

李华青 , 丘昭文 , 林冲云 . 腹膜透析对糖尿病尿毒症患者透析效果与生活质量的影响[J]. 包头医学院学报, 2017 , 33(9) : 63 -64 . DOI: 10.16833/j.cnki.jbmc.2017.09.025

Abstract

Objective: To investigate the effect of peritoneal dialysis on the dialysis effect and life quality of diabetic patients with uremia.Methods: 90 cases of patients with diabetes mellitus and uremia from August 2015 to August 2016 were enrolled and randomly divided into control group and study group, 45 cases in each group. The control group was treated by hemodialysis, and the study group was treated by peritoneal dialysis. The changes of BUN, SCr, 24h urine output, 24h urinary protein level and quality of life were observed before and 12 weeks after treatment in the two groups.Results: The levels of BUN, SCr and 24h urine protein in study group were lower than those in control group (P<0.05), and the 24h urine output in study group was higher than that in control group (P<0.05). The emotional function, physiological function, physical pain, social function and overall health score in study group were higher than those in control group (P<0.05).Conclusion: Peritoneal dialysis has significant dialysis effect in diabetic patients with uremia and can improve the quality of life, which is suitable for clinical promotion.

参考文献

[1] 史均宝,孙庆华,聂建东,等.糖尿病腹膜透析患者下肢动脉硬化闭塞症的临床状况分析[J].北京大学学报(医学版),2013,10(1):109-113.
[2] 薄天慧,高秀,赵伟,等.持续性非卧床腹膜透析患者低钾血症发生率与临床意义[J].华西医学,2013,12(6):844-846.
[3] 陈香美,周建辉.中国腹膜透析技术发展现状与未来[J].中国实用内科杂志,2013,22(6):413-415.
[4] 梁剑波,王泽彬,詹俊琳.腹膜透析患者死亡相关影响因素分析[J].广东医学,2013,30(14):2156-2159.
[5] 王青尔,周婷婷,吕桂兰,等.关键监测指标在腹膜透析患者容量管理中的应用效果[J].中华护理杂志,2014,18(6):661-666.
[6] 庹艳红,郑卫华,马特安.羟苯磺酸钙对维持性腹膜透析患者微炎症状态的影响[J].医学研究杂志,2014,25(6):147-149.
[7] 严富洪,徐天,谢静远,等.CD105在评价腹膜透析腹膜新生血管中的应用价值[J].上海医学,2014,42(5):414-418.
[8] 李冰心,周小兵,杨林,等.罗格列酮对腹膜透析患者微炎症反应状态的影响[J].中国医院药学杂志,2014,30(20):1754-1756.
[9] 郭银凤,张晓良.腹膜保护——透析液以外的影响因素[J].肾脏病与透析肾移植杂志,2013,12(4):380-384.
[10] 尹飞挺,俞雨生.腹膜透析在终末期糖尿病肾病治疗中的应用[J].肾脏病与透析肾移植杂志,2013,10(5):485-489.
文章导航

/